What Is Hereditary Spherocytosis and How Is It Treated?

Hereditary spherocytosis is the most common inherited red blood cell membrane disorder, causing red cells to lose their normal disc shape and become small, round spheres that the spleen identifies as defective and destroys prematurely. Most people with the condition have mild to moderate symptoms, but the range of severity is wide, from cases so quiet they go undiagnosed for decades to newborns who need emergency treatment within hours of birth. The underlying problem is structural: proteins that normally anchor the red cell’s flexible outer membrane to its internal skeleton are missing or defective, and that single mechanical flaw cascades into anemia, jaundice, and an enlarged spleen.

What Goes Wrong Inside the Red Blood Cell

A healthy red blood cell looks like a flattened disc with a slight indentation on each side. That shape gives it both the surface area to carry oxygen efficiently and the flexibility to squeeze through capillaries narrower than the cell itself. The shape is maintained by a mesh of skeletal proteins just beneath the cell’s outer lipid membrane, connected to that membrane by vertical anchor proteins.

In hereditary spherocytosis, one or more of those anchor proteins is deficient or abnormal. Without secure vertical connections, patches of the outer membrane peel away in tiny vesicles, especially as the cell passes through the narrow slits in the spleen’s filtering system. Each pass costs the cell a bit more surface area, but the volume of fluid inside stays roughly the same, so the cell gradually inflates from a flexible disc into a rigid sphere. Research using computational models of the spleen’s filtering slits has confirmed that this surface loss accelerates as weakened cells are forced through those gaps repeatedly.

Spherical red cells are stiff. They can no longer deform to slip through the spleen’s narrow passages, so the spleen traps and destroys them far earlier than a normal cell’s roughly 120-day lifespan. That accelerated destruction is what doctors call hemolytic anemia: the bone marrow tries to compensate by producing red cells faster, but in moderate and severe cases it cannot keep up.

Which Genes Are Involved

Five genes account for nearly all cases. A study of 166 children with hereditary spherocytosis identified a disease-causing mutation in 97% of them, distributed across four of those genes: ANK1 (encoding ankyrin) in about half, SPTB (beta-spectrin) in a third, SLC4A1 (band 3) in roughly one in eight, and SPTA1 (alpha-spectrin) in a small minority.¹ A fifth gene, EPB42, encoding protein 4.2, causes a smaller share of cases and is more common in certain populations, particularly in Japan.

Most hereditary spherocytosis follows an autosomal dominant inheritance pattern, meaning a single copy of the defective gene from one parent is enough to cause disease. If one parent is affected, each child has roughly a 50% chance of inheriting it. But there are exceptions. Severe forms linked to alpha-spectrin mutations typically require two copies of the faulty gene, one from each parent, making them autosomal recessive.² And in up to a quarter of cases, neither parent shows signs of the disease. Some of these represent new spontaneous mutations; others involve a parent who carries the gene but has such mild disease it was never noticed.

The specific gene involved influences severity. Ankyrin mutations, the most common cause, tend to produce mild to moderate disease. Band 3 mutations often cause a milder phenotype. Alpha-spectrin mutations in the recessive pattern are associated with the most severe anemia. Knowing the gene can help families understand what to expect and plan monitoring accordingly.

Symptoms and How They Vary

The classic triad is anemia, jaundice, and an enlarged spleen. But “classic” is misleading, because many people with hereditary spherocytosis never develop the full picture. Most affected individuals have only mild or moderate hemolysis, meaning their bone marrow compensates well enough that they feel fine most of the time.³ They might notice occasional fatigue or a slight yellowish tint to their skin, or they might have no symptoms at all and learn about the diagnosis only when a routine blood test turns up something unexpected.

On the other end of the spectrum, severe cases involve chronic anemia that requires regular transfusions, persistent jaundice, and a spleen swollen enough to cause discomfort. Children with severe disease may grow more slowly and can develop characteristic bone changes as the marrow expands to try to meet the demand for new red cells.

One pattern worth knowing: people with compensated hemolysis, meaning enough red cells are produced to replace those being destroyed, can feel perfectly healthy during stable periods but crash hard during infections. A bout of flu or a stomach virus can temporarily suppress the bone marrow just enough that production can no longer keep pace with destruction, and hemoglobin drops sharply. Parents of children with hereditary spherocytosis are often caught off guard by these episodes because the child seemed fine before.

Newborns and Early Detection

Hereditary spherocytosis can announce itself dramatically in the first days of life. Newborns break down fetal hemoglobin rapidly, and a baby whose red cells are already being destroyed at an accelerated rate can develop severe jaundice, known as unconjugated hyperbilirubinemia, within 24 to 48 hours of birth. Left untreated, high bilirubin levels in a newborn can damage the brain. Prompt intervention with phototherapy, and in extreme cases exchange transfusion, is critical.⁴

Not every affected newborn presents this way. Mild cases may produce jaundice just slightly above the threshold that triggers a workup, or no jaundice at all. When there is a known family history, pediatricians are usually primed to check. The trickier scenario is the baby born to parents who do not know they carry the gene, where neonatal jaundice might initially be attributed to other common causes like blood type incompatibility or breastfeeding difficulties before hereditary spherocytosis is considered.

How Hereditary Spherocytosis Is Diagnosed

A combination of family history, physical exam findings, and lab work usually points the way. On a standard blood count, a few characteristic patterns stand out: elevated mean corpuscular hemoglobin concentration (the red cells are “concentrated” because they have lost membrane but kept their hemoglobin), a high reticulocyte count as the marrow races to compensate, and spherocytes visible on a blood smear.⁵

For confirmation, the eosin-5′-maleimide (EMA) binding test has largely replaced older methods. The EMA test uses a fluorescent dye that binds to band 3 protein on the red cell surface. Spherocytic cells, having lost membrane, bind less dye and fluoresce less brightly. A large comparative study found that the EMA test detected hereditary spherocytosis with 93% sensitivity and 98% specificity, performing consistently regardless of the underlying genetic defect or how severe the disease was clinically.⁶ A more recent evaluation of the test found similarly strong numbers, reporting 96% sensitivity and about 97% specificity at an optimal cutoff.⁷

The older osmotic fragility test, which measures how easily red cells burst in progressively diluted salt solutions, was long considered the standard. But its sensitivity was only around 68% on fresh blood and 81% on incubated samples, dropping further in people with compensated disease.⁸ That means it missed roughly a third of cases on fresh samples, a significant limitation. The EMA test is simpler, more reproducible, and harder to fool.⁹ It also reliably distinguishes hereditary spherocytosis from autoimmune hemolytic anemia and iron deficiency, conditions that can mimic it on basic lab work.¹⁰

Genetic testing is available and increasingly used, especially when the clinical picture is ambiguous or when families want to identify the specific mutation for reproductive planning. It is not required for diagnosis in straightforward cases.

Gallstones and Other Complications

The most common complication of hereditary spherocytosis is gallstones. The connection is direct: accelerated red cell destruction produces excess bilirubin, which is processed by the liver and excreted into bile. When bilirubin concentrations in bile run chronically high, it crystallizes into pigment gallstones. These tend to appear at a younger age than the cholesterol-based gallstones most people associate with gallbladder disease.¹¹ It is not unusual for teenagers or even children under ten with hereditary spherocytosis to develop symptomatic gallstones. Coinheritance of Gilbert syndrome, a common and otherwise benign condition that further slows bilirubin processing, increases the gallstone risk even more.¹²

A second feared complication is aplastic crisis, usually triggered by parvovirus B19 infection (the virus behind “fifth disease” in children). Parvovirus specifically targets the precursor cells that produce new red blood cells, temporarily shutting down red cell production for about a week. For someone whose bone marrow is already working overtime to compensate for chronic hemolysis, even a brief halt in production can cause hemoglobin to plummet dangerously. These episodes can require urgent blood transfusion.¹³ The good news is that parvovirus B19 infection confers lifelong immunity, so aplastic crisis from this cause is typically a one-time event.

Megaloblastic crisis, caused by folate deficiency, is another potential issue. The bone marrow’s increased production demands consume folate at a faster-than-normal rate. Without supplementation, stores can run low, impairing red cell production at precisely the time it needs to be running at full capacity. Daily folic acid supplementation is standard practice for anyone with ongoing hemolysis. A study of Brazilian patients with hereditary spherocytosis found that those who supplemented had significantly higher serum folate and its active metabolites compared to those who did not, while unsupplemented patients actually had lower folate than healthy controls.¹⁴

Splenectomy and Its Trade-Offs

Because the spleen is where most of the red cell destruction happens, removing it (splenectomy) dramatically improves blood counts. After total splenectomy, hemoglobin rises by an average of about 3.6 g/dL within a year, and the proportion of immature red cells flooding out of the marrow drops substantially.¹⁵ The red cells are still spherical, but without the spleen aggressively filtering them out, they survive much longer in circulation. For people with moderate to severe disease, splenectomy can be life-changing.

The catch is infection risk. The spleen plays a critical role in defending against encapsulated bacteria. Without it, people are vulnerable to overwhelming post-splenectomy infection, a rare but potentially fatal sepsis that can develop within hours. This risk does not fade with time; data from long-term follow-up of patients splenectomized for hereditary spherocytosis confirm that the danger persists for life.¹⁶ Vaccination against pneumococcus, meningococcus, and Haemophilus influenzae before surgery is essential, and many patients take daily prophylactic antibiotics for years afterward. Anyone without a spleen who develops sudden high fever needs medical attention immediately, not the next morning.

This infection risk is the main reason doctors have become more conservative about recommending splenectomy, especially in children. Mild cases are often managed with observation and folic acid alone. Moderate cases prompt a conversation about timing and approach. When splenectomy is warranted in a child, many centers now prefer to delay until at least age six if possible, since the immune consequences are more severe in younger children.

Partial Versus Total Splenectomy

The idea behind partial splenectomy is appealing: remove enough of the spleen to reduce red cell destruction while leaving enough tissue to maintain some immune protection. In practice, partial splenectomy does improve blood counts, though not as dramatically as total removal. One meta-analysis found hemoglobin rose by about 2.2 g/dL after partial splenectomy compared to 3.6 g/dL after total, with the partial results remaining stable for at least six years.¹⁷ A later meta-analysis confirmed that total splenectomy produces better hematological outcomes overall, though both procedures significantly improve things compared to no surgery.¹⁸

One surgical series found that partial splenectomy controlled symptoms as effectively as total removal in their cohort, suggesting that for patients with moderate disease, the smaller procedure may be sufficient.¹⁹ The trade-off is that the remaining splenic tissue can regrow or, in cases where accessory spleens were preserved, that accessory tissue can enlarge and resume filtering at a rate that brings symptoms back. One reported case involved a child who underwent total splenectomy with deliberate preservation of an accessory spleen, only to develop hyperfunction of that accessory spleen seven years later, with recurrent hemolysis.²⁰ This is uncommon, but it underscores why ongoing follow-up matters even after surgery.

How Hereditary Spherocytosis Differs from Related Membrane Disorders

Hereditary spherocytosis is often mentioned alongside hereditary elliptocytosis, a related condition in which red cells become oval or elliptical rather than spherical. Both involve defects in the same general family of membrane skeleton proteins, but the specific proteins and the type of structural failure differ. In spherocytosis, the vertical connections between the membrane and its skeleton weaken, causing membrane loss and rounding.²¹ In elliptocytosis, the lateral connections within the skeleton itself are disrupted, so the cell can stretch but cannot snap back, leading to permanent elongation and, in severe cases, fragmentation.²²

This distinction matters clinically. Many people with hereditary elliptocytosis have no symptoms at all; their oval cells function well enough and survive a normal lifespan. Severe forms exist but are rarer. Hereditary pyropoikilocytosis, the most extreme variant of elliptocytosis, produces wildly fragmented, misshapen cells and severe anemia, but it results from a combination of a spectrin mutation and partial spectrin deficiency rather than either defect alone.²³ Electron microscopy studies have shown that even when spherocytosis and pyropoikilocytosis red cells have similar levels of spectrin deficiency, the skeleton in pyropoikilocytosis is far more disrupted, because the spectrin that remains is also functionally abnormal.

A Possible Upside Against Malaria

Several inherited red blood cell disorders are thought to have persisted in human populations partly because they offer some protection against malaria. The best-known example is sickle cell trait, but hereditary spherocytosis may share a modest version of this advantage. In laboratory experiments culturing the malaria parasite Plasmodium falciparum in different types of red cells, spherocytic cells supported the lowest levels of parasite growth alongside G6PD-deficient cells, suggesting that the altered membrane makes it harder for the parasite to invade or develop normally.²⁴

This is far from proof of evolutionary selection. Hereditary spherocytosis is most common in people of northern European descent, populations that have not faced intense malaria pressure for centuries. Whether the malaria-resistance effect played a role in maintaining the gene in other populations, or whether it is merely an incidental lab finding, remains an open question. Still, the observation is a useful reminder that genetic variants causing disease are not always purely harmful; they sometimes carry trade-offs that make evolutionary sense in certain environments.